Natco Pharma saw the highest growth of 3.99% in patent filings in June and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.49% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Natco Pharma’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Natco Pharma has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with seven publications in Q2 2024
The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings with nearly 88% of filings. The World Intellectual Property Organization(WIPO), and United States(US) patent Office are among the top ten patent offices where Natco Pharma is filings its patents..
Roche could be the strongest competitor for Natco Pharma
Patents related to rare diseases lead Natco Pharma's portfolio
Natco Pharma has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Nevus related patents lead Natco Pharma portfolio followed by squamous cell carcinoma, and head and neck cancer
Natco Pharma has highest number of patents in nevus followed by squamous cell carcinoma, head and neck cancer.
For comprehensive analysis of Natco Pharma's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
